Andrew Bellinger, CSO & CMO at Verve Therapeutics, Inc. (VERV), sold 20,000 shares at $34.90 ($698K) on 2022-07-20, disclosed to the SEC on 2022-07-22.
Open-market sale of $698k VERV by CSO & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERV | SELL | 2022-09-27 | $4.2M | — | Filing → |
| VERV | SELL | 2022-07-15 | $249K | — | Filing → |
| VERV | SELL | 2021-12-27 | $1.2M | — | Filing → |